IL155613A0 - Novel human nucleic acid molecules and polypeptides emcoding a novel human ion channel expressed in spinal cord and brain - Google Patents

Novel human nucleic acid molecules and polypeptides emcoding a novel human ion channel expressed in spinal cord and brain

Info

Publication number
IL155613A0
IL155613A0 IL15561301A IL15561301A IL155613A0 IL 155613 A0 IL155613 A0 IL 155613A0 IL 15561301 A IL15561301 A IL 15561301A IL 15561301 A IL15561301 A IL 15561301A IL 155613 A0 IL155613 A0 IL 155613A0
Authority
IL
Israel
Prior art keywords
novel human
emcoding
polypeptides
brain
nucleic acid
Prior art date
Application number
IL15561301A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL155613A0 publication Critical patent/IL155613A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
IL15561301A 2000-12-01 2001-11-30 Novel human nucleic acid molecules and polypeptides emcoding a novel human ion channel expressed in spinal cord and brain IL155613A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25058700P 2000-12-01 2000-12-01
PCT/US2001/045336 WO2002044210A2 (en) 2000-12-01 2001-11-30 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain

Publications (1)

Publication Number Publication Date
IL155613A0 true IL155613A0 (en) 2003-11-23

Family

ID=22948356

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15561301A IL155613A0 (en) 2000-12-01 2001-11-30 Novel human nucleic acid molecules and polypeptides emcoding a novel human ion channel expressed in spinal cord and brain

Country Status (8)

Country Link
US (1) US20030027164A1 (xx)
EP (1) EP1379652A2 (xx)
JP (1) JP2005506037A (xx)
AU (1) AU2002232456A1 (xx)
CA (1) CA2436941A1 (xx)
IL (1) IL155613A0 (xx)
MX (1) MXPA03004781A (xx)
WO (1) WO2002044210A2 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000722A2 (en) * 2000-06-26 2002-01-03 Millennium Pharmaceuticals, Inc. Human calcium channels (48000; 52920) and uses thereof
GB0128161D0 (en) * 2001-11-23 2002-01-16 Merck Sharp & Dohme Receptor protein
US7754856B2 (en) 2002-01-18 2010-07-13 Takeda Pharmaceutical Company Limited Human sodium-dependent bile acid transporter proteins
US20050176010A1 (en) * 2002-04-16 2005-08-11 Bayer Healthcare Ag Regulation of human transient receptor potential channel
AU2003232513A1 (en) * 2002-04-25 2003-11-10 Rheinische Friedrich-Wilhelms- Universitaet Bonn Pain receptor gene and protein
WO2004045638A1 (en) * 2002-11-18 2004-06-03 Merck Sharp & Dohme Limited Vanilloid receptor-2 ligands for treating anxiety or depression
AU2006244074B2 (en) * 2005-05-09 2012-12-13 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
US8916550B2 (en) * 2005-05-09 2014-12-23 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
TWI409070B (zh) * 2005-11-04 2013-09-21 Hydra Biosciences Inc 用於調節ｔｒｐｖ３功能之化合物
US7998980B2 (en) 2006-09-15 2011-08-16 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
WO2008140750A1 (en) * 2007-05-10 2008-11-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
US8392124B2 (en) * 2008-11-14 2013-03-05 The Invention Science Fund I, Llc Food content detector
EP2421980A2 (en) 2009-04-23 2012-02-29 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for cancer
US9314005B2 (en) 2009-07-01 2016-04-19 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for severe combined immunodeficiency (SCID)
EP3485889B1 (en) 2011-12-16 2023-09-06 Poseida Therapeutics, Inc. Trpc4 modulators for use in the treatment or prevention of pain
EP3597223A1 (en) * 2018-07-17 2020-01-22 Centre National De La Recherche Scientifique Peptides for use as cell-penetrating peptides
EP4096661A4 (en) 2020-01-29 2024-03-06 Kamari Pharma Ltd. COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISEASES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9537A (en) * 1853-01-11 Arrangement op screw-ctttting dies
US219806A (en) * 1879-09-23 Improvement in measuring devices for creating wantage
GB9713484D0 (en) * 1997-06-27 1997-09-03 Smithkline Beecham Plc Neuroprotective vanilloid compounds
ATE253111T1 (de) * 1997-08-20 2003-11-15 Univ California Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
WO1999037765A1 (en) * 1998-01-27 1999-07-29 Smithkline Beecham Plc Human vanilloid receptor homologues
EP1320600A1 (en) * 2000-08-03 2003-06-25 Incyte Genomics, Inc. Transporters and ion channels
GB2372993A (en) * 2000-11-03 2002-09-11 Smithkline Beecham Plc Vanilloid Receptor 6

Also Published As

Publication number Publication date
AU2002232456A1 (en) 2002-06-11
WO2002044210A3 (en) 2003-11-06
JP2005506037A (ja) 2005-03-03
US20030027164A1 (en) 2003-02-06
EP1379652A2 (en) 2004-01-14
CA2436941A1 (en) 2002-06-06
MXPA03004781A (es) 2004-04-20
WO2002044210A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
IL155613A0 (en) Novel human nucleic acid molecules and polypeptides emcoding a novel human ion channel expressed in spinal cord and brain
EP1379631A4 (en) HUMAN ISOLATED PROTEIN KINASES, NUCLEIC ACID MOLECULES ENCODING THESE PROTEINS KINASES, AND CORRESPONDING USES THEREOF
AU2001297625A1 (en) Nucleic acid molecules and polypeptides for a human cation channel polypeptide
IL141539A0 (en) Dna molecules and cells transfected therewith
EP1414844A4 (en) SECRETED AND ISOLATED HUMAN PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN SECRETED PROTEINS AND USE THEREOF
AU2002213450A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2001250999A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2002239256A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2002364691A8 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2003298570A8 (en) Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
AU2001271276A1 (en) Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
EP1390486A4 (en) HUMAN AMINOACYLASE ISOLATED, NUCLEIC ACID MOLECULES ENCODING HUMAN AMINOACYLASE, AND USES THEREOF
AU2002245208A1 (en) Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
EP1414863A4 (en) ISOLATED HUMAN SEPARATED PROTEINS, NUCLEIC ACID MOLECULES CODING HUMAN SEPARATED PROTEINS, AND ITS USES
EP1414422A4 (en) SECRET ISOLATED HUMAN PROTEINS, NUCLEIC ACID MOLECULES ENCODING THE SAME, AND USES THEREOF
EP1451310A4 (en) HUMAN ISOLATED PROTEIN KINASES, NUCLEIC ACID MOLECULES ENCODING HUMAN KINASE PROTEINS AND THEIR USE
AU2001288218A1 (en) Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
AU2002234023A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2001292647A1 (en) Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
EP1409004A4 (en) ISOLATED HUMAN, RAIS-SIMILAR PROTEINS, THESE HUMAN, RAS-SIMILAR PROTEIN-CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
EP1385865A4 (en) ISOLATED HUMAN KINASEPROTEINS, NUCLEIC ACID MOLECULES CODING FOR HUMAN KINASEPROTEINS AND THEIR USES
EP1383873A4 (en) ISOLATED HUMAN CHINESE PROTEINS, HUMAN KINASE PROTEIN CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
EP1373486A4 (en) ISOLATED HUMAN KINASE PROTEINS, HUMAN KINASE PROTEIN CODING NUCLEIC ACID MOLECULES AND USES THEREOF
AU2002258355A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002305843A8 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins and uses thereof